Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized,double‐blind,placebo‐controlled study |
| |
| Authors: | Udo Bavendiek,Dominik Berliner,Lukas Aguirre D vila,Johannes Schwab,Lars Maier,Sebastian A. Philipp,Andreas Rieth,Ralf Westenfeld,Christopher Piorkowski,Kristina Weber,Anja H nselmann,Maximiliane Oldhafer,Sven Schallhorn,Heiko von der Leyen,Christoph Schr der,Christian Veltmann,Stefan St rk,Michael B hm,Armin Koch,Johann Bauersachs |
| |
| Affiliation: | Udo Bavendiek,Dominik Berliner,Lukas Aguirre Dávila,Johannes Schwab,Lars Maier,Sebastian A. Philipp,Andreas Rieth,Ralf Westenfeld,Christopher Piorkowski,Kristina Weber,Anja Hänselmann,Maximiliane Oldhafer,Sven Schallhorn,Heiko von der Leyen,Christoph Schröder,Christian Veltmann,Stefan Störk,Michael Böhm,Armin Koch,Johann Bauersachs, |
| |
| Abstract: | |
| |
| Keywords: | Heart failure Cardiac glycosides Digitalis Digitoxin Clinical trial |
|
|
